I have just learnt about some tension growing around Theranos biotech startup. Looks like their advertisement strategy worked very well, giving them more than 400 million dollars of investments. However, now the whole technology is under a big question. The topic is familiar to me because last year I took part in the Biotechnology YES competition and my team presented a similar idea of diagnosing cancer relapse from a blood test. We figured out how many bottlenecks and troubles appear once you start implementing the technology. And already at that time I felt that there are a lot of unrealistic projects out there that get some funding by really good advertising but then they usually quickly die. I am not sure the same is happenning with Theranos because they are alredy very big and are running, but let’s see.